HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mendes, Suzanny Oliveira ^a   Santos, Marcelo Dos ^a,b   Peterle, Gabriela Tonini ^a   Maia, Lucas De Lima ^a   Stur, Elaine ^a   Agostini, Lidiane Pignaton ^a   De Carvalho, Marcos Brasilino ^c   Tajara, Eloiza Helena ^d   Louro, Iúri Drumond ^a   Trivilin, Leonardo Oliveira ^a   Da Silva Conforti, Adriana Madeira Álvares ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c HOSPITAL HELIÓPOLIS   (Brazil)

^d FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LYMPHOCYTES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84893448690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084923     Document Type: Article

References (23)

1. Bauman JE, Michel LS, Chung CH (2012) New promising molecular targets in head and neck squamous cell carcinoma. Curr Opin Oncol 24: 235-242.
2. Lim YC, Choi EC (2008) Surgery alone for squamous cell carcinoma of the oral cavity: survival rates, recurrence patterns, and salvage treatment. Acta Otolaryngol.128: 1132-1137.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].Lyon, France: International Agency for Research on Cancer; 2010. Available: http://globocan.iarc.fr. Accessed 20 July 2012.
4. Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194-200.
5. Binahmed A, Nason RW, Abdoh AA (2007) The clinical significance of the positive surgical margin in oral cancer. Oral Oncol 43:780-784. (Pubitemid 47259444)
6. Yadav GS, Donoghue M, Tauro DP, Yadav A, Agarwal S (2013) Intraoperative Imprint Evaluation of Surgical Margins in Oral Squamous Cell Carcinoma. Acta Cytologica 57:75-83.
7. Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: 515-520.
8. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
9. Dehne N, Brune B (2009) HIF-1 in the inflammatory microenvironment. Exp Cell Res 315: 1791-1797.
10. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
11. Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33(4): 207-214.
12. Kaya AO, Gunel N, Benekli M, Akyurek N, Buyukberber S, et al (2012) Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. J Buon 17 (4): 663-8.
13. Kim JH, Park MY, Kim CN, Kim KH, Kang HB, et al. (2012) Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Onc Rep 28(5):1701-8.
14. Santos MD, Mercante AMDC, Louro ID, Gonçalves AJ, Carvalho MBD, et al. (2012) HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity. PLoS ONE 7(9): e45228.
15. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, et al (2007) Targeted Deletion of HIF-1a Gene in T Cells Prevents their Inhibition in Hypoxic Inflamed Tissues and Improves Septic Mice Survival. PLoS ONE 2(9): e853.
16. Sitkovsky M, Lukashevv D (2005) Regulation of immune cells by local-tissue oxygen tension:HIF1 alpha and adenosine receptors. Nat Rev Immunol 5(9):712-21. (Pubitemid 43086172)
17. Deschler DG, Day T (2008) Pocket Guide to Neck Dissection and Classification and TNM Staging of Head and Neck Cancer. American Academy of Otolaryngology-Head and Neck Surgery Foundation. 28 p.
18. Soini Y, Kahlos K, Puhakka A, Lakari E, Saily M, et al. (2000) Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma. Br J Cancer 3: 880-886.
19. Campos AH, Aldred VL, Ribeiro KC, Vassallo J, Soares FA (2009) Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma. Mol Cell Biochem 321: 95-102.
20. Mohammed ZMA, Going JJ, Edwards J, McMillan DC (2012) The role of the tumor inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treatment Reviews 38: 943-955.
21. Tougeron D, Maby P, Elie N, Fauquembergue E', Le Pessot F, et al. (2013) Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers. PLoS ONE 8(4): e61001.
22. Dong M, Wan X, Yuan ZY, Wei L, Fan XJ, et al. (2013) Low expression of Beclin 1 and elevated expression of HIF-1a refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol 30:355.
23. Palazón A, Martínez-Forero I, Teijeira A, Morales-Kastresana A, Alfaro C, et al. (2012) The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy. Cancer Discov 2(7):608-23.